Not all hair loss treatments are equal, and the market is full of products that outpace their evidence. For men with androgenetic alopecia, the decision about which treatment to use should be based on clinical data, the stage of hair loss, cost, and realistic expectations. This article ranks the major treatment options from the most to least established, explains what each does mechanistically, and outlines what men can realistically expect from each approach.
What Causes the Hair Loss These Treatments Target
The majority of hair loss in men is androgenetic alopecia: a genetically driven response to dihydrotestosterone (DHT) that causes follicle miniaturization at the temples and crown. ( 1 ) DHT is converted from testosterone by the enzyme 5-alpha reductase. The susceptibility of a man’s follicles to DHT is inherited from both parents and varies widely between individuals.
Secondary causes of hair loss, including telogen effluvium (stress-related shedding), nutritional deficiency, and autoimmune alopecia areata, require different treatment approaches. The treatments ranked below are specifically validated for androgenetic alopecia unless otherwise noted.
How Each Treatment Works
1. Finasteride: Highest Evidence, Oral DHT Blocker
Finasteride is the top-ranked treatment for male androgenetic alopecia based on clinical evidence and mechanism. It inhibits type II 5-alpha reductase, reducing DHT production in the scalp by a substantial margin. ( 2 ) In pivotal trials published in the Journal of the American Academy of Dermatology, finasteride significantly increased hair count and slowed progression compared to placebo over two years, with durable results maintained through five years of continued use. It requires a prescription and ongoing use; stopping treatment typically results in resumed hair loss within twelve months.
2. Minoxidil: Strong Evidence, Topical or Oral
Minoxidil is the other FDA-approved treatment for male pattern hair loss. Unlike finasteride, it does not address DHT; instead, it prolongs the anagen (active growth) phase of the hair cycle and is thought to improve follicle vascularity. ( 3 ) Topical minoxidil applied twice daily has strong clinical support for slowing hair loss and stimulating modest regrowth. Oral minoxidil has emerged as an alternative with growing clinical evidence showing superior systemic effect, though it carries a different side effect profile. Research published in the Journal of the American Academy of Dermatology has compared oral and topical formulations, finding oral minoxidil effective at lower doses in men with androgenetic alopecia. ( 4 ) Combining minoxidil with finasteride yields greater results than either alone.
3. PRP Therapy: Emerging Evidence, Regenerative Approach
Platelet-rich plasma therapy involves drawing the patient’s blood, centrifuging it to concentrate platelets and growth factors, and injecting the resulting plasma into the scalp. ( 5 ) Growth factors in PRP, including platelet-derived growth factor (PDGF) and vascular endothelial growth factor (VEGF), are hypothesized to stimulate follicle activity and prolong anagen. A meta-analysis published in Dermatologic Surgery found that PRP significantly improved hair density and thickness in men with androgenetic alopecia compared to control conditions. ( 6 ) However, protocol standardization (preparation method, concentration, injection frequency) varies significantly between providers, making outcome predictability lower than for pharmaceutical treatments. PRP works best as an adjunct to proven medical therapies rather than a standalone replacement.
4. Low-Level Laser Therapy (LLLT): Modest Evidence, Non-Invasive
Low-level laser therapy devices, including laser caps and combs, use specific wavelengths of light to stimulate follicle metabolism. ( 7 ) The FDA has cleared several LLLT devices as treatments for hair loss, though clearance is not the same as approval and does not require demonstration of efficacy equivalent to pharmaceutical trials. Clinical studies, including a randomized controlled trial published in the American Journal of Clinical Dermatology, have shown modest improvements in hair density with LLLT compared to sham devices. ( 8 ) It is safe, non-invasive, and can complement other treatments, but should not be considered a primary therapy for significant hair loss.
5. Hair Transplant Surgery: Permanent, for Established Loss
Hair transplant surgery, using either Follicular Unit Extraction (FUE) or Follicular Unit Transplantation (FUT), relocates DHT-resistant follicles from the occipital scalp to areas of thinning or baldness. ( 9 ) Results are permanent because the transplanted follicles retain their genetic resistance to DHT in their new location. Transplants are best suited for men with stabilized, established hair loss rather than those in early or rapidly progressing stages. They do not prevent continued loss in non-transplanted areas, which is why maintaining medical therapy (finasteride, minoxidil) post-surgery is typically recommended. Cost ranges from several thousand to tens of thousands of dollars depending on the extent of treatment.
Treatment Options: Combining Approaches
The most effective strategy for most men with androgenetic alopecia involves layering treatments. A commonly recommended protocol in clinical practice starts with finasteride to address the DHT mechanism, adds minoxidil for follicle support, and may incorporate PRP or LLLT as adjuncts. Surgery is reserved for men with advanced, stable loss who want to restore density in areas where medical therapy alone cannot achieve sufficient regrowth.
If you are also managing testosterone levels or considering hormonal optimization, the interaction between testosterone therapy and hair loss is worth understanding in depth. Our article on testosterone replacement therapy covers those dynamics. Similarly, if you are concerned about how hormonal changes may be contributing to thinning, reviewing what low testosterone means provides a useful baseline.
Common Myths About Hair Loss Treatments
Myth: Natural or herbal supplements are as effective as finasteride. Saw palmetto, biotin, and similar supplements are frequently marketed for hair loss. None have clinical evidence comparable to FDA-approved treatments. A review published in the Journal of Drugs in Dermatology found the evidence for most supplement-based hair loss remedies to be limited and inconsistent. ( 10 )
Myth: Hair transplants are a cure and need no follow-up treatment. Transplanted follicles are DHT-resistant, but native follicles in the surrounding scalp are not. Without ongoing medical treatment, men can continue to lose ground around transplanted areas, creating an unnatural appearance over time.
Myth: PRP alone is sufficient for significant hair loss. PRP shows genuine promise, particularly as an adjunct therapy, but the variability in protocols and patient response means it should not replace first-line pharmaceutical treatments for men with moderate to advanced androgenetic alopecia.
When to See a Doctor
Any man noticing consistent hair thinning should seek evaluation before significant loss has occurred. The earlier a treatment plan is implemented, the more follicular activity is preserved. A dermatologist or men’s health physician can confirm the pattern, rule out non-androgenetic causes, and recommend a treatment protocol appropriate for the stage and pace of loss.
Men with additional hormonal symptoms should have their testosterone levels assessed by age as part of a complete evaluation. Hair loss is sometimes the most visible symptom of a broader hormonal picture that warrants attention.
Start with What Works
The best hair loss treatment is the one you start early and stay consistent with. Finasteride and minoxidil remain the most evidence-backed options for the majority of men with androgenetic alopecia. If you are ready to stop watching your hairline change and start doing something about it, connect with a men’s health physician who can build a treatment plan based on your pattern, goals, and health profile.
Emergency Notice: If you or someone else is experiencing a medical emergency, call 911 immediately. The information on this site is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
References
- Trüeb RM. Molecular mechanisms of androgenetic alopecia. Experimental Gerontology. 2002;37(8–9):981–990. https://doi.org/10.1016/S0531-5565(02)00093-1
- Kaufman KD, Olsen EA, Whiting D, et al. Finasteride in the treatment of men with androgenetic alopecia. Journal of the American Academy of Dermatology. 1998;39(4):578–589. https://doi.org/10.1016/S0190-9622(98)70007-6
- Messenger AG, Rundegren J. Minoxidil: mechanisms of action on hair growth. British Journal of Dermatology. 2004;150(2):186–194. https://doi.org/10.1111/j.1365-2133.2004.05785.x
- Jimenez-Cauhe J, Ortega-Quijano D, Prieto-Barrios M, et al. Effectiveness and safety of low-dose oral minoxidil in male androgenetic alopecia. Journal of the American Academy of Dermatology. 2021;85(4):1001–1003. https://doi.org/10.1016/j.jaad.2020.11.064
- Marx RE. Platelet-rich plasma: evidence to support its use. Journal of Oral and Maxillofacial Surgery. 2004;62(4):489–496. https://doi.org/10.1016/j.joms.2003.12.003
- Giordano S, Romeo M, Lankinen P. Platelet-rich plasma for androgenetic alopecia: does it work? Evidence from meta-analysis. Journal of Cosmetic Dermatology. 2017;16(3):374–381. https://doi.org/10.1111/jocd.12331
- Avram MR, Rogers NE. The use of low-level light for hair growth: part I. Journal of Cosmetic and Laser Therapy. 2009;11(2):110–117. https://doi.org/10.1080/14764170902842531
- Lanzafame RJ, Blanche RR, Bodian AB, et al. The growth of human scalp hair mediated by visible red light laser and LED sources in males. Lasers in Surgery and Medicine. 2013;45(8):487–495. https://doi.org/10.1002/lsm.22162
- Unger WP, Shapiro R. Hair Transplantation. 4th ed. New York: Marcel Dekker; 2004.
- Suchonwanit P, Srisuwanwattana P, Chalermroj N, Khunkhet S. A randomized, double-blind controlled study of the efficacy and safety of topical solution of 0.25% finasteride admixed with 3% minoxidil vs. 3% minoxidil solution in the treatment of male androgenetic alopecia. Journal of the European Academy of Dermatology and Venereology. 2018;32(12):2257–2263. https://doi.org/10.1111/jdv.15171